Quest Diagnostics, Inc. DGX

NYS: DGX | ISIN: US74834L1008 16/09/2025

180,16 USD (-0,25%)

(-0,25%) 16/09/2025

Grafiek Quest Diagnostics, Inc.

Grafiek Quest Diagnostics, Inc.

1 dag1d -0,25%
1 week1w -1,80%
1 maand1m 0,68%
3 maanden3m 0,21%
6 maanden6m 4,47%
1 jaar1j 15,87%
5 jaar5j 58,22%

Quest Diagnostics, Inc. in het nieuws

Toon enkel gratis nieuws

16 september 2025 · Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference · Persbericht

4 september 2025 · Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering · Persbericht

2 september 2025 · Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index · Persbericht

26 augustus 2025 · Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan · Persbericht

25 augustus 2025 · FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics · Persbericht

16 augustus 2025 · Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference · Persbericht

14 augustus 2025 · Quest Diagnostics Declares Quarterly Cash Dividend · Persbericht

7 augustus 2025 · Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types · Persbericht

5 augustus 2025 · Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care · Persbericht

29 juli 2025 · Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing · Persbericht

Profiel Quest Diagnostics, Inc.

Diensten aan de gezondheidssector

Gezondheidszorg

Tandheelkundige laboratoria

Website: www.questdiagnostics.com

Hoofdzetel: Secaucus, New Jersey Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe